Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
SBIO
90
HOLDINGS
16%
ALSO IN IBRN
IBRN
60
HOLDINGS
33%
ALSO IN SBIO
SECTOR DRIFT (SBIO minus IBRN)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
AXSOME THERAPEUTICS, INC. | 3.4% | 4.2% | 3.4% |
|
PTC THERAPEUTICS INC | 2.7% | 4.8% | 2.7% |
 |
ALKERMES PLC | 2.1% | 3.3% | 2.1% |
|
ACADIA PHARMACEUTICALS INC | 1.8% | 3.2% | 1.8% |
|
DENALI THERAPEUTICS INC. | 1.2% | 3.4% | 1.2% |
SBIO Overweight Relative to IBRN
|
AVIDITY BIOSCIENCES INC | 4.7% |
|
CYTOKINETICS INC | 3.5% |
 |
MERUS N.V. | 3.2% |
|
RHYTHM PHARMACEUTICALS, INC. | 3.1% |
|
NUVALENT, INC. CLASS A | 3.1% |
|
VAXCYTE, INC. | 2.7% |
|
KRYSTAL BIOTECH, INC. | 2.7% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 2.5% |
|
PROTAGONIST THERAPEUTICS, INC. | 2.3% |
|
ARCELLX, INC. | 2.1% |
SBIO Underweight Relative to IBRN
|
SCHOLAR ROCK HOLDING CORP. | -4.5% |
|
BIOGEN IDEC INC | -4.3% |
 |
ARGENX SE ADR | -4.3% |
|
CATALYST PHARMACEUTICAL PART | -3.9% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.6% |
|
DYNE THERAPEUTICS INC | -3.5% |
|
SUPERNUS PHARMACEUTICALS INC | -3.4% |
|
NEUROCRINE BIOSCIENCES INC | -3.4% |
|
SAREPTA THERAPEUTICS INC | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.3% |